文献速递垂体与肾上腺疾病

VAV2表达评估可优化肾上腺皮质癌的预后预测

Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

研究纳入来自七个欧洲肾上腺肿瘤研究网络中心的171例肾上腺皮质癌(ACC)病例,以H评分量化VAV2表达(低<2,高≥2),并将Ki67标记指数分为低(<20%)和高(≥20%)。VAV2表达与Ki67 LI显著相关,且二者均与无进展生存期(PFS)和总生存期(OS)显著相关;联合评估VAV2表达与Ki67 LI可改善患者低危和高危分层。

要点

  • VAV2表达与Ki67 LI显著相关,且二者均与PFS和OS显著相关。
  • VAV2表达在同一个肿瘤内的异质性很低。
  • 联合评估VAV2表达与Ki67 LI可改善ACC患者的低危和高危分层。

核心结论

  • 联合评估Ki67 LI和VAV2表达可改善ACC的预后预测。

研究设计与样本

  • 研究纳入来自七个欧洲肾上腺肿瘤研究网络中心的171例ACC病例(157例原发肿瘤、6例局部复发、8例转移)。

主要发现

  • VAV2表达与Ki67 LI显著相关,且二者均与PFS和OS显著相关。
  • 同一个肿瘤内VAV2表达的异质性很低。
  • 联合评估VAV2表达和Ki67 LI可改善患者向低危和高危组的分层。

关键数值与推荐

  • VAV2表达以H评分量化,分为低(H评分<2)和高(H评分≥2)两类。
  • Ki67 LI分为低(<20%)和高(≥20%)两类。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with overall poor prognosis. The Ki67 labeling index (LI) has a major prognostic role in localized ACC after complete resection, but its estimates may suffer from considerable intra- and interobserver variability. VAV2 overexpression induced by increased Steroidogenic Factor-1 dosage is an essential factor driving ACC tumor cell invasion. OBJECTIVE: To assess the prognostic role of VAV2 expression in ACC by investigation of a large cohort of patients. DESIGN, SETTING, AND PARTICIPANTS: A total of 171 ACC cases (157 primary tumors, six local recurrences, eight metastases) from seven European Network for the Study of Adrenal Tumors centers were studied. OUTCOME MEASUREMENTS: H-scores were generated to quantify VAV2 expression. VAV2 expression was divided into two categories: low (H-score, <2) and high (H-score, ≥2). The Ki67 LI retrieved from patients' pathology records was also categorized into low (<20%) and high (≥20%). Clinical and immunohistochemical markers were correlated with progression-free survival (PFS) and overall survival (OS). RESULTS: VAV2 expression and Ki67 LI were significantly correlated with each other and with PFS and OS. Heterogeneity of VAV2 expression inside the same tumor was very low. Combined assessment of VAV2 expression and Ki67 LI improved patient stratification to low-risk and high-risk groups. CONCLUSION: Combined assessment of Ki67 LI and VAV2 expression improves prognostic prediction in ACC.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Sbiera S, Sbiera I, Ruggiero C, et al. Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma. J Clin Endocrinol Metab. 2017. PMID: 28911143. doi:10.1210/jc.2017-00984

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。